Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract

被引:10
|
作者
Aquino, Rita P. [1 ]
Auriemma, Giulia [1 ]
Conte, Giulio M. [1 ]
Esposito, Tiziana [1 ]
Sommella, Eduardo [1 ]
Campiglia, Pietro [1 ]
Sansone, Francesca [1 ]
机构
[1] Univ Salerno, Dept Pharm, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy
来源
MOLECULES | 2020年 / 25卷 / 09期
关键词
Spirulina extract; peptides; nutraceutical products; microencapsulation via spray drying; technological properties; stability; in vitro intestinal permeation; INTESTINAL-ABSORPTION; CHITOSAN; PERMEABILITY; TECHNOLOGY; ENHANCERS; POWDER;
D O I
10.3390/molecules25092086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HSE shows critical organoleptic characteristics also having poor intestinal permeability, limiting absorption when orally delivered. This research aims to overcome the critical issues through the encapsulation of HSE in Chitosan/Mannitol-(CM)-based microparticles by spray drying. The produced powders (CM-HSE) showed good process yield (approximate to 70%) and encapsulation efficiency (approximate to 100%) also having good derived flow properties as well as stability up to six months storage. The microparticles constituting the spray-dried powder resulted in an amorphous micrometric state (d(50) approximate to 14 mu m) able to retain dark colour and unpleasant smell of raw HSE. Moreover, the in vitro permeation study by Franz cell indicated that the engineered microparticles are able to enhance the permeation of HSE through an intestinal biomimetic barrier (551.13 mu g/cm(2) CM-HSE vs. 315.46 mu g/cm(2) HSE at 270 min).
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan
    Jiang, Tao
    Singh, Bijay
    Li, Hui-Shan
    Kim, You-Kyoung
    Kang, Sang-Kee
    Nah, Jae-Woon
    Choi, Yun-Jaie
    Cho, Chong-Su
    BIOMATERIALS, 2014, 35 (07) : 2365 - 2373
  • [22] Interpolymer complex microparticles based on polymethacrylic acid-chitosan for oral insulin delivery
    Sajeesh, S
    Sharma, CP
    JOURNAL OF APPLIED POLYMER SCIENCE, 2006, 99 (02) : 506 - 512
  • [23] Chitosan/alginate microparticles for the oral delivery of fowl typhoid vaccine: Innate and acquired immunity
    Onuigbo, Ebele
    Iseghohimhen, Joy
    Chah, Kennedy
    Gyang, Moses
    Attama, Anthony
    VACCINE, 2018, 36 (33) : 4973 - 4978
  • [24] Preparation and Characterization of Chitosan Microparticles for Oral Sustained Delivery of Gliclazide: In Vitro/In Vivo Evaluation
    Barakat, Nahla S.
    Almurshedi, Alanood S.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (03) : 235 - 246
  • [25] Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration
    Zaichik, Sergey
    Steinbring, Christian
    Caliskan, Cagri
    Bernkop-Schnuerch, Andreas
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 554 : 125 - 133
  • [26] Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats
    Gradauer, K.
    Barthelmes, J.
    Vonach, C.
    Almer, G.
    Mangge, H.
    Teubl, B.
    Roblegg, E.
    Duennhaupt, S.
    Froehlich, E.
    Bernkop-Schnuerch, A.
    Prassl, R.
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (03) : 872 - 878
  • [27] The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation
    Wong, Chun Y.
    Al-Salami, Hani
    Dass, Crispin R.
    JOURNAL OF DRUG TARGETING, 2018, 26 (07) : 551 - 562
  • [28] Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration
    Hecq, J.
    Siepmann, F.
    Siepmann, J.
    Amighi, K.
    Goole, J.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (12) : 2037 - 2044
  • [29] Development of new chitosan-cellulose multicore microparticles for controlled drug delivery
    Remunan-Lopez, C
    Lorenzo-Lamosa, ML
    Vila-Jato, JL
    Alonso, MJ
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (01) : 49 - 56
  • [30] Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines
    Chua, Brendon Y.
    Al Kobaisi, Mohammad
    Zeng, Weiguang
    Mainwaring, David
    Jackson, David C.
    MOLECULAR PHARMACEUTICS, 2012, 9 (01) : 81 - 90